Archive | Cancer in the News

EMA’s CHMP Recommends Yervoy for Patients 12 and Older with Advanced Melanoma

Yervoy (ipilimumab) has received a positive review by the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP), recommending its approval for the treatment of unresectable or metastatic melanoma in patients age 12 and older.

Read the full story

Posted in Melanoma In The News, European Approval

FDA Approves Opdivo For Resected Melanoma

The FDA approved nivolumab injection for the adjuvant treatment of patients with melanoma who have involved lymph nodes or metastatic disease and who underwent complete resection.

Read the full story

Posted in Melanoma In The News, FDA

FDA Grants Adjuvant Dabrafenib/Trametinib Priority Review for BRAF + Melanoma

The FDA has granted a priority review to a supplemental new drug application (sNDA) for the use of dabrafenib (Tafinlar) combined with trametinib (Mekinist) as an adjuvant treatment for patients with BRAF V600E– or V600K–positive stage III melanoma following complete resection.

Read the full story

Posted in Melanoma In The News, FDA

FDA Greenlights Nivolumab as an Adjuvant Melanoma Therapy

Yesterday, nivolumab (Opdivo) was granted regular approval for the treatment of patients with melanoma whose disease spread to the lymph nodes or those with metastatic disease who have undergone resection, according to a press release.

Read the full story

Posted in Melanoma In The News, FDA

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories